SCHEMBL17203430

SCHEMBL17203430

Cc1cc(-c2cc(Br)cnc2N)sn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.44
▸ HTT P42858 2/20 0.44
▸ PIK3CD O00329 2/20 0.40
▸ PIK3CB P42338 2/20 0.40
▸ PIK3CG P48736 2/20 0.40
▸ NPC1 O15118 1/20 0.38
▸ MEN1 O00255 4/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP2A6 P11509 2/20 0.33
▸ DYRK1A Q13627 2/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ LRRK2 Q5S007 2/20 0.33
▸ UHRF1 Q96T88 1/20 0.32
▸ NOS3 P29474 1/20 0.32
▸ NOS1 P29475 1/20 0.32
▸ NOS2 P35228 1/20 0.32
▸ POLB P06746 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17203507 0.77 PIK3CD (0.49) KMT2AHTTPIK3CDPIK3CBPIK3CG
SCHEMBL17255919 0.75 KMT2A (0.65) KMT2AHTTNPC1MEN1ALDH1A1
SCHEMBL26916550 0.73 KMT2A (0.44) KMT2AHTTNPC1MEN1ALDH1A1
SCHEMBL29858013 0.73 KMT2A (0.44) KMT2AHTTNPC1MEN1ALDH1A1
SCHEMBL17203223 0.72 PIK3CD (0.50) KMT2AHTTPIK3CDPIK3CBPIK3CG
SCHEMBL2222921 0.70 USP7 (0.51) KMT2AHTTLRRK2MAP4K4
SCHEMBL27742561 0.70 RAB9A (0.50) KMT2AHTTNPC1MEN1ALDH1A1
SCHEMBL2222927 0.70 KMT2A (0.44) KMT2AHTTPIK3CDPIK3CBPIK3CG
SCHEMBL17203383 0.70 KMT2A (0.44) KMT2AHTTPIK3CDPIK3CBPIK3CG
SCHEMBL8119368 0.69 UHRF1 (0.34) KMT2AHTTUHRF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3134396-B1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2019-09-18 — — EP disclosed
EP-3134396-B1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2019-09-18 — — EP disclosed
US-10112926-B2 Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors NOVARTIS AG (CH) 2018-10-30 — — US disclosed
EP-3134396-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS Novartis AG (CH) 2017-03-01 — — EP disclosed
US-20170037032-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2017-02-09 — — US disclosed
US-20170037032-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2017-02-09 — — US disclosed
US-20170037032-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2017-02-09 — — US disclosed
WO-2015162456-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2015-10-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170037032-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS PI4KA, PIP4K2B, PHKG1 KMT2A 2520/4885HTT 4793/4885PIK3CD 15/4885
US-10112926-B2 Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors PI4KA, PIP4K2B, PHKG1 KMT2A 2520/4885HTT 4793/4885PIK3CD 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback